StockMacro
Company, fund or insider

Help

Menu

Passage Bio

$3.92 -29% in 6 monthsMarket cap $12.6M

PASG on XNAS, Health Care, Passage Bio, Inc., job postings

Measures activity, not value. Not investment advice.

Received a delisting notice while cash of $20.2M trails a $33.1M 12-month net loss.

  • WatchShares down 47% over 12 months, but up 9.2% in one month

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
24
Website
passagebio.com
Listed
Nasdaq, US
Last results
3 Mar 2026
Next results
no estimate
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $4.7M.
Quarter to 31 Dec 2021: revenue –, net income -$51.2MQuarter to 31 Mar 2022: revenue –, net income -$42.8MQuarter to 30 Jun 2022: revenue –, net income -$39.5MQuarter to 30 Sep 2022: revenue –, net income -$26.7MQuarter to 31 Dec 2022: revenue –, net income -$27.1MQuarter to 31 Mar 2023: revenue –, net income -$34.3MQuarter to 30 Jun 2023: revenue –, net income -$23.9MQuarter to 30 Sep 2023: revenue –, net income -$27.1MQuarter to 31 Dec 2023: revenue –, net income -$16.8MQuarter to 31 Mar 2024: revenue –, net income -$16.7MQuarter to 30 Jun 2024: revenue –, net income -$16.0MQuarter to 30 Sep 2024: revenue –, net income -$19.3MQuarter to 31 Dec 2024: revenue –, net income -$12.7MQuarter to 31 Mar 2025: revenue –, net income -$15.4MQuarter to 30 Jun 2025: revenue –, net income -$9.4MQuarter to 30 Sep 2025: revenue –, net income -$7.7MQuarter to 31 Dec 2025: revenue –, net income -$13.0MQuarter to 31 Mar 2026: revenue –, net income -$7.6MQuarter to 30 Jun 2026: revenue –, net income -$7.8MQuarter to 30 Sep 2026: revenue –, net income -$4.7M
31 Dec 2021RevenueNet incomeNet losstallest bar $51.2M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$4.7M
30 Jun 2026–-$7.8M
31 Mar 2026–-$7.6M
31 Dec 2025–-$13.0M
30 Sep 2025–-$7.7M
30 Jun 2025–-$9.4M
31 Mar 2025–-$15.4M
31 Dec 2024–-$12.7M
30 Sep 2024–-$19.3M
30 Jun 2024–-$16.0M
31 Mar 2024–-$16.7M
31 Dec 2023–-$16.8M
30 Sep 2023–-$27.1M
30 Jun 2023–-$23.9M
31 Mar 2023–-$34.3M
31 Dec 2022–-$27.1M
30 Sep 2022–-$26.7M
30 Jun 2022–-$39.5M
31 Mar 2022–-$42.8M
31 Dec 2021–-$51.2M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$33.1M -$45.3M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$10.35 -$10.47
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -212% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $20.2M $52.8M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.02
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 252 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Passage BioPASG (this company) $12.6Mloss–––
BioStem TechnologiesBSEM $12.2M––––
BioCardiaBCDA $11.9Mloss–––
Acumen PharmaceuticalsABOS $13.5Mloss–––
PluriPLUR $13.5Mloss9.3+10%–
Dyadic InternationalDYAI $11.5Mloss3.7-7.6%-227%

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-3.3%

29 13F filers vs 30

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

41%

1.3M shares held by 13F filers (30 Sep 2026) of 3.2M outstanding (6 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

1.5%

50K shares sold short (30 Oct 2026) of 3.2M outstanding (6 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.0

50K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-28%

69K shares sold short in the report before, 50K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

63%

63% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 43%

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

27

reported for the year to 31 Jan 2024

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

20

20 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

20 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $3.92 on 20 Nov 2026, -47% over 12 months (12-month range $3.32 to $19.85)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $93K in the last 12 months (the 12 months before: $360K).
Institutional holders (13F filers). 29 13F filers reported holding it in the latest 13F quarter, -9.4% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, capital spending per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
18 Nov 20268-K and other filingsReceived Nasdaq letter: stockholders' equity of $50,000 below $2.5M minimum; company expects Remix mergers to regain compliance
6 Nov 20268-K and other filingsDirector or officer change
6 Nov 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Jun 20268-K and other filingsDirector or officer change
24 Jun 20268-K and other filingsA major agreement ended
24 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 May 20268-K and other filingsA major agreement ended
28 Apr 20268-K and other filingsRestructuring costs announced
10 Mar 20268-K and other filingsA major agreement ended
18 Sep 20258-K and other filingsDirector or officer change
18 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
31 Jan 20258-K and other filingsDelisting notice or listing transfer
14 Jan 2025Sharp changeShort interest spike: short interest spike, 3.9M vs usual 1.7M (2024-12-31); 10.0x the same period a year earlier
10 Jan 20258-K and other filingsAsset write-down (impairment)
10 Jan 20258-K and other filingsRestructuring costs announced
10 Sep 20248-K and other filingsDirector or officer change
6 Sep 20248-K and other filingsAsset write-down (impairment)
27 Aug 2024Sharp changeShort interest spike: short interest spike, 1.8M vs usual 350K (2024-08-15); 8.7x the same period a year earlier
13 Aug 2024Sharp changeShort interest spike: short interest spike, 1.9M vs usual 297K (2024-07-31); 10.3x the same period a year earlier
2 Aug 20248-K and other filingsDelisting notice or listing transfer
1 Aug 20248-K and other filingsDirector or officer change
1 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Jul 2024Sharp changeShort interest spike: short interest spike, 1.7M vs usual 270K (2024-07-15); 7.1x the same period a year earlier
16 Jul 2024Sharp changeShort interest spike: short interest spike, 1.7M vs usual 257K (2024-06-28); 7.6x the same period a year earlier
2 Jul 2024Sharp changeShort interest spike: short interest spike, 1.7M vs usual 257K (2024-06-14); 5.5x the same period a year earlier
18 Jun 2024Sharp changeShort interest spike: short interest spike, 1.7M vs usual 257K (2024-05-31); 6.2x the same period a year earlier
28 May 2024Sharp changeShort interest spike: short interest spike, 1.7M vs usual 256K (2024-05-15); 6.6x the same period a year earlier
14 May 2024Sharp changeShort interest spike: short interest spike, 1.8M vs usual 256K (2024-04-30); 6.1x the same period a year earlier
30 Apr 2024Sharp changeShort interest spike: short interest spike, 1.8M vs usual 256K (2024-04-15); 5.4x the same period a year earlier
16 Apr 2024Sharp changeShort interest spike: short interest spike, 1.3M vs usual 256K (2024-03-28); 3.6x the same period a year earlier
2 Apr 2024Sharp changeShort interest spike: short interest spike, 1.2M vs usual 256K (2024-03-15); 3.7x the same period a year earlier
12 Mar 2024Sharp changeShort interest spike: short interest spike, 558K vs usual 256K (2024-02-29); 1.7x the same period a year earlier
4 Mar 20248-K and other filingsDirector or officer change
4 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Sep 20238-K and other filingsDelisting notice or listing transfer
31 Jul 20238-K and other filingsDirector or officer change
20 Jul 20238-K and other filingsDirector or officer change
20 Jul 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
10 Nov 20228-K and other filingsDirector or officer change
11 Oct 20228-K and other filingsDirector or officer change
11 Oct 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Jul 20228-K and other filingsDirector or officer change
1 Jun 20228-K and other filingsDirector or officer change
11 Mar 20228-K and other filingsDirector or officer change
11 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Jan 2022: $3.7M published
Month from 1 Mar 2022: $32K published
Month from 1 May 2022: $1.0M published
Month from 1 Nov 2022: -$7K published
Month from 1 Dec 2022: -$6K published
Month from 1 Apr 2023: -$2K published
Month from 1 Jun 2023: $998K published
Month from 1 Aug 2023: -$10K published
Month from 1 Jan 2024: -$38K published
Month from 1 Feb 2024: -$3K published
Month from 1 Sep 2024: -$175K published
Month from 1 Nov 2024: $284K published
Month from 1 Dec 2024: -$268K published
Month from 1 Jan 2025: -$3K published
Month from 1 Feb 2025: -$2K published
Month from 1 Apr 2025: -$128K published
Month from 1 Jun 2025: -$197K published
Month from 1 Jul 2025: $734K published
Month from 1 Sep 2025: $224K published
Month from 1 Jan 2026: -$113K published
Month from 1 Jun 2026: $206K published
Institutional holders (13F filers)
31 Dec 2021 report: 94; public on 14 Feb 2022
31 Mar 2022 report: 105; public on 16 May 2022
30 Jun 2022 report: 83; public on 15 Aug 2022
30 Sep 2022 report: 70; public on 14 Nov 2022
31 Dec 2022 report: 63; public on 14 Feb 2023
31 Mar 2023 report: 55; public on 15 May 2023
30 Jun 2023 report: 51; public on 14 Aug 2023
30 Sep 2023 report: 48; public on 14 Nov 2023
31 Dec 2023 report: 47; public on 14 Feb 2024
31 Mar 2024 report: 49; public on 15 May 2024
30 Jun 2024 report: 44; public on 14 Aug 2024
30 Sep 2024 report: 42; public on 14 Nov 2024
31 Dec 2024 report: 46; public on 14 Feb 2025
31 Mar 2025 report: 42; public on 15 May 2025
30 Jun 2025 report: 39; public on 14 Aug 2025
30 Sep 2025 report: 32; public on 14 Nov 2025
31 Dec 2025 report: 30; public on 17 Feb 2026
31 Mar 2026 report: 35; public on 15 May 2026
30 Jun 2026 report: 30; public on 14 Aug 2026
30 Sep 2026 report: 29; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $206K (29 Jun 2026), higher than 73% of its own history.
  • Insider net buying (open market): Insiders bought a net $93K in the last 12 months (the 12 months before: $360K).
  • Institutional holders (13F filers): 29 13F filers reported holding it in the latest 13F quarter, -9.4% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 58 insider trades

No trades in the last 90 days; the latest was filed 29 Jun 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
29 Jun 2026Weston Nichols and 1 other10% ownerBuy50,055$4.12$206KForm 4
12 Jan 2026Kathleen BorthwickCFOSellafter exercising options2,062$18.44$38KForm 4
12 Jan 2026William ChouPRESIDENT AND CEOSellafter exercising options4,076$18.44$75KForm 4
15 Sep 2025Weston Nichols and 1 other10% ownerBuy32,008$6.99$224KForm 4
24 Jul 2025Lynx1 Capital Management LP and 1 other10% ownerBuy128,848$5.69$734KForm 4
26 Jun 2025Orbimed Advisors LLC and 1 other10% ownerSell583,657$0.34$197KForm 4
24 Apr 2025Orbimed Advisors LLC and 1 other10% ownerSell235,572$0.33$79KForm 4
17 Apr 2025OrbiMed Capital GP VII LLC and 1 other10% ownerSell149,054$0.33$50KForm 4

29 institutions reported shares at the end of Q3 2026, 41% of the shares outstanding; 3 opened a position, 4 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Lynx1 Capital Management LP674K20.9%$3.0MNo change
Nantahala Capital Management, LLC127K3.96%$573KNew+127K
Yiheng Capital Management, L.P.86K2.68%$387KNo change
Vanguard Capital Management LLC73K2.26%$327K-41K-36%
Verdad Advisers, LP58K1.80%$261K+27K+89%
Balyasny Asset Management L.P.50K1.54%$223K-58K-54%
Renaissance Technologies LLC47K1.46%$211K-1,000-2.1%
Erste Asset Management GmbH41K1.26%$188KNo change
Geode Capital Management, LLC37K1.15%$167KNo change
BlackRock, Inc.28K0.87%$126KNo change

Company events

All 42 company events

In 12 months: 3 agreements ended, 2 major agreements, 2 director or officer changes, 1 restructuring. Results releases and routine reports are left out.

FiledWhat happenedSource
18 Nov 2026Received Nasdaq letter: stockholders' equity of $50,000 below $2.5M minimum; company expects Remix mergers to regain compliance8-K
6 Nov 2026Director or officer changeSame filing: shareholder vote results8-K
2 Sep 2026Signed a major agreementSame filing: sold shares privately8-K
24 Jun 2026Director or officer change; Signed a major agreement; A major agreement endedSame filing: sold shares privately, change of control8-K
27 May 2026A major agreement ended8-K
28 Apr 2026Restructuring costs announced8-K
10 Mar 2026A major agreement ended8-K
18 Sep 2025Director or officer change8-K

The 5 newest of 54 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 18 Nov 2026Filings record

    Received Nasdaq letter: stockholders' equity of $50,000 below $2.5M minimum; company expects Remix mergers to regain compliance

  2. 6 Nov 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 6 Nov 2026Filings record

    Director or officer change

  4. 30 Jun 2026Insiders record

    Nichols Weston (ten percent owner) and 1 other(s) bought 50,055 shares of PASG ($206,227) (dated 29 Jun 2026)

  5. 24 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 24 Jun 2026Filings record

    Director or officer change

  7. 24 Jun 2026Filings record

    A major agreement ended

  8. 27 May 2026Filings record

    A major agreement ended

  9. 28 Apr 2026Filings record

    Restructuring costs announced

  10. 10 Mar 2026Filings record

    A major agreement ended

  11. 18 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 18 Sep 2025Filings record

    Director or officer change

  13. 16 Sep 2025Insiders record

    Nichols Weston (ten percent owner) and 1 other(s) bought 32,008 shares of PASG ($223,726) (dated 15 Sep 2025)

  14. 25 Jul 2025Insiders record

    Lynx1 Capital Management LP (ten percent owner) and 1 other(s) bought 128,848 shares of PASG ($733,658) (dated 24 Jul 2025)

  15. 31 Jan 2025Filings record

    Delisting notice or listing transfer

  16. 14 Jan 2025Short interest and volume change

    had 3.9M shares sold short in the 31 Dec 2024 report, 10× the same report last year.

    Same report last year: 384K; its normal report is 1.7M.

    See the evidence
    This period
    3.9M (the 31 Dec 2024 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    76K
    How far from its usual level
    +13.1
    Same report last year
    384K
    History used
    1,754 days
    2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M2024-04-15: 1.8M2024-04-30: 1.8M2024-05-15: 1.7M2024-05-31: 1.7M2024-06-14: 1.7M2024-06-28: 1.7M2024-07-15: 1.7M2024-07-31: 1.9M2024-08-15: 1.8M2024-08-30: 1.7M2024-09-13: 1.8M2024-09-30: 1.7M2024-10-15: 1.7M2024-10-31: 1.6M2024-11-15: 1.6M2024-11-29: 1.7M2024-12-13: 1.7M2024-12-31: 3.9M
    the 31 Dec 2024 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 10 Jan 2025Filings record

    Asset write-down (impairment)

  18. 10 Jan 2025Filings record

    Restructuring costs announced

  19. 1 Jan 2025Insiders record

    Lynx1 Capital Management LP (ten percent owner) and 1 other(s) bought 373,645 shares of PASG ($242,869) (dated 31 Dec 2024)

  20. 28 Nov 2024Insiders record

    Lynx1 Capital Management LP (ten percent owner) and 1 other(s) bought 456,353 shares of PASG ($283,839) (dated 27 Nov 2024)

  21. 10 Sep 2024Filings record

    Director or officer change

  22. 6 Sep 2024Filings record

    Asset write-down (impairment)

  23. 27 Aug 2024Short interest and volume change

    had 1.8M shares sold short in the 15 Aug 2024 report, 8.7× the same report last year.

    Same report last year: 205K; its normal report is 350K.

    See the evidence
    This period
    1.8M (the 15 Aug 2024 report)
    Normal report (median of 24 earlier)
    350K
    Typical spread (median absolute deviation)
    147K
    How far from its usual level
    +6.6
    Same report last year
    205K
    History used
    1,616 days
    2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M2024-04-15: 1.8M2024-04-30: 1.8M2024-05-15: 1.7M2024-05-31: 1.7M2024-06-14: 1.7M2024-06-28: 1.7M2024-07-15: 1.7M2024-07-31: 1.9M2024-08-15: 1.8M
    the 15 Aug 2024 report24 earlier reportsnormal: 350K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 10 Aug 2024Short interest and volume change

    had 1.9M shares sold short in the 31 Jul 2024 report, 10× the same report last year.

    Same report last year: 182K; its normal report is 297K.

    See the evidence
    This period
    1.9M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    297K
    Typical spread (median absolute deviation)
    94K
    How far from its usual level
    +11.2
    Same report last year
    182K
    History used
    1,601 days
    2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M2024-04-15: 1.8M2024-04-30: 1.8M2024-05-15: 1.7M2024-05-31: 1.7M2024-06-14: 1.7M2024-06-28: 1.7M2024-07-15: 1.7M2024-07-31: 1.9M
    the 31 Jul 2024 report24 earlier reportsnormal: 297K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 2 Aug 2024Filings record

    Delisting notice or listing transfer

  26. 1 Aug 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 1 Aug 2024Filings record

    Director or officer change

  28. 25 Jul 2024Short interest and volume change

    had 1.7M shares sold short in the 15 Jul 2024 report, 7.1× the same report last year.

    Same report last year: 239K; its normal report is 270K.

    See the evidence
    This period
    1.7M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    270K
    Typical spread (median absolute deviation)
    68K
    How far from its usual level
    +14.1
    Same report last year
    239K
    History used
    1,585 days
    2023-07-14: 239K2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M2024-04-15: 1.8M2024-04-30: 1.8M2024-05-15: 1.7M2024-05-31: 1.7M2024-06-14: 1.7M2024-06-28: 1.7M2024-07-15: 1.7M
    the 15 Jul 2024 report24 earlier reportsnormal: 270K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 11 Jul 2024Short interest and volume change

    had 1.7M shares sold short in the 28 Jun 2024 report, 7.6× the same report last year.

    Same report last year: 221K; its normal report is 257K.

    See the evidence
    This period
    1.7M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    257K
    Typical spread (median absolute deviation)
    54K
    How far from its usual level
    +17.8
    Same report last year
    221K
    History used
    1,568 days
    2023-06-30: 221K2023-07-14: 239K2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M2024-04-15: 1.8M2024-04-30: 1.8M2024-05-15: 1.7M2024-05-31: 1.7M2024-06-14: 1.7M2024-06-28: 1.7M
    the 28 Jun 2024 report24 earlier reportsnormal: 257K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 27 Jun 2024Short interest and volume change

    had 1.7M shares sold short in the 14 Jun 2024 report, 5.5× the same report last year.

    Same report last year: 300K; its normal report is 257K.

    See the evidence
    This period
    1.7M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    257K
    Typical spread (median absolute deviation)
    49K
    How far from its usual level
    +19.3
    Same report last year
    300K
    History used
    1,554 days
    2023-06-15: 300K2023-06-30: 221K2023-07-14: 239K2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M2024-04-15: 1.8M2024-04-30: 1.8M2024-05-15: 1.7M2024-05-31: 1.7M2024-06-14: 1.7M
    the 14 Jun 2024 report24 earlier reportsnormal: 257K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 12 Jun 2024Short interest and volume change

    had 1.7M shares sold short in the 31 May 2024 report, 6.2× the same report last year.

    Same report last year: 269K; its normal report is 257K.

    See the evidence
    This period
    1.7M (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    257K
    Typical spread (median absolute deviation)
    45K
    How far from its usual level
    +21.1
    Same report last year
    269K
    History used
    1,540 days
    2023-05-31: 269K2023-06-15: 300K2023-06-30: 221K2023-07-14: 239K2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M2024-04-15: 1.8M2024-04-30: 1.8M2024-05-15: 1.7M2024-05-31: 1.7M
    the 31 May 2024 report24 earlier reportsnormal: 257K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 25 May 2024Short interest and volume change

    had 1.7M shares sold short in the 15 May 2024 report, 6.6× the same report last year.

    Same report last year: 260K; its normal report is 256K.

    See the evidence
    This period
    1.7M (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    256K
    Typical spread (median absolute deviation)
    40K
    How far from its usual level
    +24.7
    Same report last year
    260K
    History used
    1,524 days
    2023-05-15: 260K2023-05-31: 269K2023-06-15: 300K2023-06-30: 221K2023-07-14: 239K2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M2024-04-15: 1.8M2024-04-30: 1.8M2024-05-15: 1.7M
    the 15 May 2024 report24 earlier reportsnormal: 256K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 10 May 2024Short interest and volume change

    had 1.8M shares sold short in the 30 Apr 2024 report, 6.1× the same report last year.

    Same report last year: 291K; its normal report is 256K.

    See the evidence
    This period
    1.8M (the 30 Apr 2024 report)
    Normal report (median of 24 earlier)
    256K
    Typical spread (median absolute deviation)
    35K
    How far from its usual level
    +29.2
    Same report last year
    291K
    History used
    1,509 days
    2023-04-28: 291K2023-05-15: 260K2023-05-31: 269K2023-06-15: 300K2023-06-30: 221K2023-07-14: 239K2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M2024-04-15: 1.8M2024-04-30: 1.8M
    the 30 Apr 2024 report24 earlier reportsnormal: 256K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 25 Apr 2024Short interest and volume change

    had 1.8M shares sold short in the 15 Apr 2024 report, 5.4× the same report last year.

    Same report last year: 322K; its normal report is 256K.

    See the evidence
    This period
    1.8M (the 15 Apr 2024 report)
    Normal report (median of 24 earlier)
    256K
    Typical spread (median absolute deviation)
    35K
    How far from its usual level
    +29.0
    Same report last year
    322K
    History used
    1,494 days
    2023-04-14: 322K2023-04-28: 291K2023-05-15: 260K2023-05-31: 269K2023-06-15: 300K2023-06-30: 221K2023-07-14: 239K2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M2024-04-15: 1.8M
    the 15 Apr 2024 report24 earlier reportsnormal: 256K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 10 Apr 2024Short interest and volume change

    had 1.3M shares sold short in the 28 Mar 2024 report, 3.6× the same report last year.

    Same report last year: 369K; its normal report is 256K.

    See the evidence
    This period
    1.3M (the 28 Mar 2024 report)
    Normal report (median of 24 earlier)
    256K
    Typical spread (median absolute deviation)
    35K
    How far from its usual level
    +20.7
    Same report last year
    369K
    History used
    1,476 days
    2023-03-31: 369K2023-04-14: 322K2023-04-28: 291K2023-05-15: 260K2023-05-31: 269K2023-06-15: 300K2023-06-30: 221K2023-07-14: 239K2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M2024-03-28: 1.3M
    the 28 Mar 2024 report24 earlier reportsnormal: 256K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  36. 27 Mar 2024Short interest and volume change

    had 1.2M shares sold short in the 15 Mar 2024 report, 3.7× the same report last year.

    Same report last year: 327K; its normal report is 256K.

    See the evidence
    This period
    1.2M (the 15 Mar 2024 report)
    Normal report (median of 24 earlier)
    256K
    Typical spread (median absolute deviation)
    35K
    How far from its usual level
    +18.6
    Same report last year
    327K
    History used
    1,463 days
    2023-03-15: 327K2023-03-31: 369K2023-04-14: 322K2023-04-28: 291K2023-05-15: 260K2023-05-31: 269K2023-06-15: 300K2023-06-30: 221K2023-07-14: 239K2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K2024-03-15: 1.2M
    the 15 Mar 2024 report24 earlier reportsnormal: 256K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 12 Mar 2024Short interest and volume change

    had 558K shares sold short in the 29 Feb 2024 report, 1.7× the same report last year.

    Same report last year: 335K; its normal report is 256K.

    See the evidence
    This period
    558K (the 29 Feb 2024 report)
    Normal report (median of 24 earlier)
    256K
    Typical spread (median absolute deviation)
    35K
    How far from its usual level
    +5.9
    Same report last year
    335K
    History used
    1,448 days
    2023-02-28: 335K2023-03-15: 327K2023-03-31: 369K2023-04-14: 322K2023-04-28: 291K2023-05-15: 260K2023-05-31: 269K2023-06-15: 300K2023-06-30: 221K2023-07-14: 239K2023-07-31: 182K2023-08-15: 205K2023-08-31: 200K2023-09-15: 210K2023-09-29: 249K2023-10-13: 237K2023-10-31: 228K2023-11-15: 262K2023-11-30: 241K2023-12-15: 245K2023-12-29: 384K2024-01-12: 316K2024-01-31: 278K2024-02-15: 251K2024-02-29: 558K
    the 29 Feb 2024 report24 earlier reportsnormal: 256K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 4 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 4 Mar 2024Filings record

    Director or officer change

  40. 1 Sep 2023Filings record

    Delisting notice or listing transfer

Showing the newest 40 of 97 entries; narrow the window or the kind of data to see older ones.

Not listed: 113 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001787297
Ticker
PASG
Domain
passagebio.com
Hq location
PA|PHILADELPHIA|19103 (1 unverified)
Name
Passage Bio, Inc.
  • SEC Form 13F institutional holdings243 data points31 Mar 2020 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)121 records5 Sep 2019 to 19 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)365 data points31 Dec 2018 to 6 Nov 2026
  • SEC Form 4 insider transactions58 records, 148 data points3 Mar 2020 to 29 Jun 2026
  • FINRA short interest (twice monthly)476 data points13 Mar 2020 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3386 data points28 Feb 2020 to 20 Nov 2026